(AGENPARL) – SILVER SPRING mar 11 aprile 2023 An In-Depth Look at the Final FDA Guidance: Bioavailability Studies Submitted in NDAs or INDs – General Considerations
Fonte/Source: http://www.fda.gov/drugs/news-events-human-drugs/depth-look-final-fda-guidance-bioavailability-studies-submitted-ndas-or-inds-general-considerations